 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
1 to 6 of 6 results |
|
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
Klein W. on NEWS: San Diego: Oligomers Live Up to Bad Reputation, Part 1, Editor’s note: The Alzforum editors invited Bill Klein of Northwestern University’s... 19 Dec 2007.
|
 |
 |
 |
 |
 |
De Felice F, Klein W, Zhao W. on NEWS: How Does Aβ Do Harm? New Clues on Insulin Signaling, Spines, Inflammation, We acknowledge Dr. Pimplikar's understandable concern regarding Akt. We would like to call... 8 Oct 2007.
|
 |
 |
 |
 |
 |
Klein W, Krafft G. on NEWS: Immunotherapy Protects against Synaptic Effects of Soluble Amyloid-β Oligomers, This study represents an important advance in establishing solid in vivo proof-of-concept for... 30 Apr 2005.
|
 |
 |
 |
 |
 |
Klein W. on NEWS: Oligomers in AD: Too Much of a Bad Thing?, Response to comment by Vincent Marchesi
Dr. Marchesi provides a thoughtful summary of our... 29 Aug 2003.
|
 |
 |
 |
 |
 |
Klein W. on NEWS: One-Shot Deal? Mice Regain Memory Day After Vaccination, Plaques Stay Put, The remarkable finding described by Dodart et al. in Nature Neuroscience adds an important page... 14 Apr 2002.
|
 |
 |
 |
 |
 |
Klein W. on NEWS: Normal Prion Protein Signals with Fyn, Coupling of cellular prion proteins to Fyn is a real surprise, but
maybe it shouldn't be. Fyn... 14 Sep 2000.
|
 |
 |
 |
 |
 |
 |
1 to 6 of 6 results |
|
 |
|
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Should the FDA be allowed to use data from overseas clinical trials? |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Absolutely, we are running out of viable subjects in the U.S. |
 |
 |
 |
 |
 |
 |
9 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Yes, so long as the data is reliable |
 |
 |
 |
 |
 |
 |
31 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
No, the trials are not as rigorous |
 |
 |
 |
 |
 |
 |
3 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
No, the data should be repeated in the U.S. |
 |
 |
 |
 |
 |
 |
5 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
No, the drug sponsors are just trying to cut corners |
 |
 |
 |
 |
 |
 |
3 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Responses: 51 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
|
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Archived Polls |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |

|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |